Prosterit 5 KOCAK

£39.00

Prosterit 5 KOCAK finasteride tablets provide researchers with pharmaceutical-grade material for investigating 5α-reductase inhibition in laboratory studies. Professional-grade formulation for precise research protocols.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Prosterit 5 KOCAK
Prosterit 5 KOCAK
£39.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications of Prosterit 5 KOCAK

Prosterit 5 KOCAK is a pharmaceutical-grade finasteride formulation designed for comprehensive laboratory research into 5α-reductase enzyme inhibition mechanisms. This research chemical enables scientists to examine the biochemical pathways involved in dihydrotestosterone (DHT) synthesis and its subsequent physiological effects in controlled experimental environments. Researchers at Stroid UK Shop utilise this compound to investigate hormonal balance modulation and androgen metabolism in cellular and tissue-based studies.

The compound demonstrates particular value in endocrinological research examining the relationship between testosterone conversion and androgenic activity. Laboratory investigations focus on evaluating how 5α-reductase type II inhibition affects DHT-dependent processes at the molecular level. Research teams studying androgen receptor interactions frequently incorporate this material into their experimental protocols to analyse downstream signalling cascades and gene expression patterns.

Molecular Characteristics and Research Profile

Each Prosterit 5 KOCAK tablet contains precisely measured active pharmaceutical ingredients optimised for research consistency. The formulation enables reproducible experimental conditions across multiple study iterations, supporting robust data collection in hormonal research applications. Scientists examining aromatase inhibitor mechanisms frequently compare this compound’s selective enzyme inhibition properties against other research chemicals in their laboratories.

Research applications extend to investigating the compound’s effects on steroidogenesis pathways, particularly the conversion of testosterone to dihydrotestosterone via 5α-reductase enzyme systems. Laboratory studies examine how selective inhibition influences androgen-dependent cellular processes, including protein synthesis modulation and receptor binding affinity changes. These investigations contribute valuable data to broader research programmes studying hormonal regulation mechanisms.

Technical Specifications

Prosterit 5 KOCAK Research Specifications
Parameter Specification
Active Ingredient Finasteride
Dosage Form Tablets
Manufacturer KOCAK
Research Grade Pharmaceutical
Storage Requirements Room temperature, dry conditions
CAS Number 98319-26-7
Molecular Formula C₂₃H₃₆N₂O₂
Molecular Weight 372.55 g/mol

Research teams investigating selective androgen receptor modulators often incorporate this compound into comparative studies examining different approaches to androgen pathway modulation. Additionally, laboratories studying peptide interactions with steroid pathways utilise this material to understand complex hormonal networking systems.

Laboratory Research Compliance

This product is manufactured exclusively for in-vitro research applications and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory safety protocols and institutional approval before commencing any studies involving this material. All investigations should comply with applicable research regulations and institutional review board requirements.

Related